fluorodeoxyglucose f18 has been researched along with Oropharyngeal Neoplasms in 143 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (4.20) | 18.2507 |
| 2000's | 24 (16.78) | 29.6817 |
| 2010's | 76 (53.15) | 24.3611 |
| 2020's | 37 (25.87) | 2.80 |
| Authors | Studies |
|---|---|
| Awad, Z; Bujoreanu, I; Gujral, D; Wallitt, K | 1 |
| Aryal, M; Bhambhani, C; Bhangale, A; Brenner, JC; Brummel, C; Cao, Y; Casper, K; Chinn, S; Gu, W; Haring, CT; Heft Neal, M; Lee, C; Malloy, K; McHugh, JB; Mierzwa, M; Mills, RE; Prince, ME; Schonewolf, C; Shah, J; Shuman, A; Spector, ME; Sun, Y; Swiecicki, PL; Tewari, M; Worden, FP | 1 |
| Broglie, MA; Hüllner, MW; Lekanne Dit Deprez, LW; Morand, GB; Pazahr, S; Thüring, C | 1 |
| Ludlow, D; Muller, RG; Weidenbecher, M | 1 |
| Marcus, C; Subramaniam, RM | 1 |
| Avey, GD; Brower, JV; Bruce, JY; Burr, AR; Chandereng, T; Harari, PM; Hartig, GK; Hu, R; Kimple, RJ; Labby, ZE; Wieland, AM; Witek, ME; Yu, M | 1 |
| Chan, C; Cheng Lau, Y; Dempsey, MF; Dyab, H; Grose, D; Hendry, F; James, A; Lamb, C; Maxfield, C; Paterson, C; Rulach, R; Schipani, S; Wilson, C; Zhou, S | 1 |
| Akhtar, F; Beadle, BM; Colevas, AD; Divi, V; Gensheimer, MF; Harandi, N; Holsinger, FC; Le, QT; Liang, R; Liu, Y; Miller, JA; Moradi, F; Nguyen, NK; Pollom, EL; Ren, Y; Sundaram, V; Weng, Y; Zhang, C | 1 |
| Cardin, A; Dhillon, K; Dixon, B; Flatman, S; Fua, T; J R Magarey, M; Kleid, S; Manji, J; Prasad, J; Rischin, D; Tapia, M | 1 |
| Born, D; Broglie, MA; Hüllner, MW; Kovacs, Z; Maurer, A; Morand, GB; Nemes, CM; Nemmour, A; Pazahr, S; Rupp, NJ; Serrallach, B; Stadler, TM; Stoeckli, SJ | 1 |
| Baroni, S; Chiara, A; Deantoni, C; Del Vecchio, A; Dell'Oca, I; Di Muzio, NG; Fiorino, C; Mori, M; Olivieri, M; Picchio, M; Spezi, E | 1 |
| Cho, H; Jo, KH; Kang, WJ; Kim, J; Lee, SK; Park, K; Sohn, B; Woo, C | 1 |
| Chen, M; Chen, TM; Chen, WM; Shia, BC; Wu, SY | 1 |
| Allen, SG; Aryal, M; Brenner, JC; Cao, Y; Casper, KA; Chinn, SB; Elliott, DA; Malloy, KM; Mierzwa, ML; Prince, ME; Rosen, BS; Rosko, AJ; Schipper, MJ; Schonewolf, CA; Shah, JL; Shuman, AG; Spector, ME; Stucken, CL; Swiecicki, PL; Wong, KK; Worden, FP | 1 |
| Bahig, H; Bélair, M; De-Meric-de-Bellefon, M; Filion, E; Landry, D; Lavigne, D; Létourneau-Guillon, L; Nguyen-Tan, FP; O'Sullivan, B | 1 |
| Fowler, A; Holloway, L; Lee, M; Lin, P; Min, M | 1 |
| Hartel, G; Khoo, D; Liu, ZY; Punyadeera, C; Vasani, S | 1 |
| Bernsdorf, M; Friborg, J; Gothelf, A; Håkansson, K; Kristensen, CA; Lindegaard, AM; Specht, L; Vogelius, I | 1 |
| Christensen, JT; Fischer, BM; Friborg, J; Håkansson, K; Jensen, JS; Löfgren, J; Rasmussen, JH; Vogelius, IR; von Buchwald, C; Zamani, M | 1 |
| Benevolo, M; Farneti, A; Gangemi, E; Marzi, S; Pasqualoni, R; Pellini, R; Rollo, F; Ruberto, E; Sanguineti, G; Sciuto, R; Spasiano, F; Sperati, F; Vidiri, A | 1 |
| Andreu-Arasa, VC; Fujima, N; Meibom, SK; Mercier, GA; Sakai, O; Truong, MT | 1 |
| Admard, J; Breuer, T; Clasen, K; Gatidis, S; Hilke, FJ; la Fougère, C; Leibfarth, S; Nann, D; Nikolaou, K; Ossowski, S; Riess, O; Schroeder, C; Thorwarth, D; Welz, S; Winter, RM; Zips, D | 1 |
| Al-Mamgani, A; Gouw, ZAR; La Fontaine, MD; Sonke, JJ; van de Kamer, JB; Vogel, WV | 1 |
| Barney, CL; Bhatt, A; Blakaj, D; Diavolitsis, V; Eckstein, JM; Gamez, M; Grecula, JC; Healy, E; Jain, A; McElroy, JP; Miller, E; Mitchell, DL; Nolan, N; Washington, I; Wobb, JL; Wright, CL | 1 |
| De Felice, F; Guerrero Urbano, T; Humbert-Vidan, L; King, A; Lei, M | 1 |
| Brizel, DM; Choudhury, KR; Das, S; Mowery, YM; Niedzwiecki, D; Rushing, CN; Vergalasova, I; Wong, TZ; Wu, Q; Yoo, DS | 1 |
| Bradford, C; Casper, KA; Chapman, CH; Chinn, SB; Chotchutipan, T; Eisbruch, A; Ibrahim, M; Malloy, KM; McLean, SA; Mierzwa, ML; Miller, JE; Prince, MEP; Rosen, BS; Rosko, AJ; Schonewolf, CA; Shah, JL; Shuman, AG; Spector, ME; Stucken, CL; Sun, Y; Swiecicki, PL; Wilkie, JR; Worden, FP | 1 |
| Adjogatse, D; Barrington, S; Evans, M; Guerrero Urbano, T; Jayaprakasam, V; Lei, M; Michaelidou, A; Palaniappan, N; Pike, L; Rackely, T; Sanchez-Nieto, B; Suh, Y; Thomas, C; Woodley, O | 1 |
| Goel, A; Patel, Y; Rana, D; Saini, SK; Srivastava, S; Suryanarayana, K | 1 |
| Choi, KH; Hong, JH; Kim, MS; Kim, YS; Lee, YS; Park, EY; Song, JH; Sun, DI; Yoo, IR | 1 |
| Cai, J; Cheng, NM; Huo, Y; Lee, LY; Liao, CT; Lin, CY; Lu, L; Nogues, I; Wang, HM; Xiao, J; Yao, J; Ye, X; Yen, TC; Zhang, L; Zhao, K; Zhao, S; Zhou, W | 1 |
| Brizel, DM; Chang, Y; Lafata, KJ; Liu, JG; Mowery, YM; Niedzwiecki, D; Vergalasova, I; Wang, C; Yin, FF; Yoo, DS | 1 |
| Bernsdorf, M; Berthelsen, AK; Friborg, J; Gothelf, AB; Kjems, J; Kristensen, CA; Loft, A; Vogelius, IR; von Buchwald, C | 1 |
| Fujimoto, K; Hoshikawa, H; Ihara-Nishishita, A; Kobata, T; Kudomi, N; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Yamamoto, Y | 1 |
| Irizarry, R; Mathews, F; Rosenfeld, R; Sundaram, K | 1 |
| Andreu-Arasa, VC; Fujima, N; Hirata, K; Homma, A; Kano, S; Kudo, K; Meibom, SK; Mercier, GA; Sakai, O; Truong, MT; Yasuda, K | 1 |
| de Patoul, N; Denis, JM; Differding, S; Grégoire, V; Hermand, N; Lee, JA; Nuyts, S; Sterpin, E; Vanstraelen, B | 1 |
| Castelijns, JA; Comans, EF; Coupé, VM; de Bree, R; de Graaf, P; Greuter, MJ; Hoekstra, OS; Schouten, CS | 1 |
| Alongi, P; Broggi, S; Dell Oca, I; Di Muzio, NG; Fallanca, F; Fiorino, C; Gianolli, L; Incerti, E; Kirienko, M; Mapelli, P; Picchio, M; Vanoli, EG | 1 |
| Apte, AP; Deasy, JO; Folkert, MR; Grkovski, M; Lee, NY; Oh, JH; Schöder, H; Setton, J; Thorstad, WL; Young, RJ | 1 |
| Gvetadze, SR; Ilkaev, KD; Li, J; Lv, M; Sun, J; Xiong, P; Yang, X | 1 |
| Chang, JT; Cheng, NM; Fang, YD; Lee, LY; Liao, CT; Ng, SH; Tsan, DL; Wang, HM; Yang, LY; Yen, TC | 1 |
| Choi, JW; Han, M; Kim, SY; Lee, D; Lee, SJ | 1 |
| Frank, SJ; Fuller, CD; Garden, AS; Gunn, GB; Johnson, JM; Morrison, W; Mott, FE; Ng, SP; Phan, J; Rosenthal, DI; Skinner, HD; Sturgis, EM; Williams, MD | 1 |
| Adkins, DR; Chin, RI; Dehdashti, F; DeWees, TA; Floberg, JM; Garsa, AA; Gay, HA; Nussenbaum, B; Oppelt, PJ; Thorstad, WL | 1 |
| Drew, ZJ | 1 |
| Abele, J; Biron, V; Cooper, T; Harris, J; Isaac, A; O' Connell, DA; Puttagunta, L; Seikaly, H; Sivarajah, S; Zhang, H | 1 |
| Kuwabara, H; Tateishi, U; Toda, K; Toriihara, A; Yoshimura, R; Yuasa-Nakagawa, K | 1 |
| Chotchutipan, T; Eisbruch, A; El Naqa, I; Hawkins, PG; Lee, JY; Mierzwa, ML; Rosen, BS; Saripalli, AL; Thakkar, D | 1 |
| Bernard, A; Brown, E; Foote, M; Gandhi, M; Liu, HY; Lock, G; McGrath, M; Milne, R; Panizza, BJ; Porceddu, SV | 1 |
| Al-Mamgani, A; de Ridder, M; Gouw, ZAR; Hamming-Vrieze, O; Jasperse, B; Navran, A; van den Brekel, MWM; Vogel, WV | 1 |
| Flavell, RR; Ha, P; Raghavan, K; Small, EJ; Wen, KW | 1 |
| Al-Mamgani, A; Gouw, ZAR; La Fontaine, MD; Sonke, JJ; van de Kamer, JB; van Kranen, S; van Werkhoven, E; Vogel, WV | 1 |
| Harada, H; Hayashi, K; Hino, M; Imai, Y; Ito, K; Kikuchi, M; Shimizu, K; Shinohara, S; Yamashita, D | 1 |
| Abgral, R; Benoudiba, F; de Mones, E; Garcia, G; Garrel, R; Mouawad, F; Pondaven, S; Russ, G; Rysman, B; Tronche, S; Zerdoud, S | 1 |
| Hanai, N; Hasegawa, Y; Hirakawa, H; Hosoi, H; Kawakita, D; Masui, T; Nishio, M; Ozawa, T; Terada, A | 1 |
| Cho, KJ; Joo, YH; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Beadle, BM; Debnam, JM; Frank, SJ; Fuller, CD; Garden, AS; Glisson, BS; Gunn, GB; Morrison, WH; Phan, J; Rosenthal, DI; Sturgis, EM | 1 |
| Zafereo, ME | 1 |
| Chan, SC; Chang, JT; Huang, SF; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Chang, JT; Cheng, NM; Fang, YH; Huang, CG; Liao, CT; Lin, CY; Ng, SH; Tsan, DL; Wang, HM; Yen, TC | 1 |
| Alluri, KC; Koch, W; Quon, H; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Bradford, CR; Carey, T; Chepeha, DB; Eisbruch, A; McHugh, JB; Spector, ME; Stenmark, MH; Vainshtein, JM; Wolf, GT; Wong, KK; Worden, FP | 1 |
| Eisbruch, A; Vainshtein, JM | 1 |
| Sabour, S | 1 |
| Harada, H; Hino, M; Imai, Y; Itoh, K; Kanazawa, Y; Kikuchi, M; Kishimoto, I; Koyasu, S; Naito, Y; Shinohara, S; Tona, R; Usami, Y | 1 |
| Lee, NY; Lim, R; Lok, B; Rao, S; Riaz, N; Romesser, PB; Schöder, H; Setton, J; Sherman, EJ; Spratt, DE | 1 |
| Anelli, V; Covello, R; Kayal, R; Manciocco, V; Marucci, L; Mercante, G; Pellini, R; Pichi, B; Sanguineti, G; Sciuto, R; Sperduti, I; Spriano, G; Turri-Zanoni, M; Vidiri, A | 1 |
| Alluri, KC; Chung, CH; Koch, W; Subramaniam, RM; Tahari, AK; Wahl, RL | 1 |
| Chang, JT; Cheng, NM; Fang, YH; Hsu, CH; Lee, LY; Liao, CT; Ng, SH; Tsan, DL; Wang, HM; Yang, LY; Yen, TC | 1 |
| Bhuta, S; Huang, YT; Ravi Kumar, AS | 1 |
| Bloemena, E; Boellaard, R; Braakhuis, BJ; Brakenhoff, RH; de Bree, R; Doornaert, PA; Hakim, S; Hoekstra, OS; Leemans, CR; Schouten, CS; Witte, BI | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, EE; Lee, DS; Pak, K | 1 |
| Chan, SC; Chang, CJ; Chang, JT; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Beitler, JJ; Corey, A; El-Deiry, MW; Galt, J; Higgins, K; Hudgins, PA; Kendi, AT; Magliocca, K; Nickleach, DC; Saba, NF; Schuster, DM; Wadsworth, JT | 1 |
| Frey, S; Hoermann, K; Piniol, R; Sadick, H; Sadick, M; Schoenberg, SO; Weiss, C | 1 |
| Ang, KK; Foote, R; Garden, AS; Harari, P; Harris, J; Holland, J; Jones, CU; Le, QT; Levering, A; Opanowski, A; Rosenthal, DI; Schwartz, DL; Trotti, AM; Yao, M; Zhang, Q | 1 |
| Barragán, AM; Differding, S; Janssens, G; Lee, JA; Sterpin, E | 1 |
| Kang, WJ; Kim, J; Koh, YW; Lee, JH; Shin, NY; Sohn, B | 1 |
| Choi, SH; Kim, JS; Kim, JW; Kim, SY; Nam, SY; Oh, JS; Roh, JL | 1 |
| Chang, JT; Cheng, NM; Fang, YH; Lee, LY; Liao, CT; Ng, SH; Tsan, DL; Wang, HM; Yang, LY; Yen, TC | 1 |
| Glatz, S; Guckenberger, M; Hemmatazad, H; Huber, G; Ikenberg, K; Klöck, S; Lang, S; Nesteruk, M; Pruschy, M; Riesterer, O; Stieb, S; Studer, G; Veit-Haibach, P | 1 |
| Bayman, E; Bird, D; Carey, B; Karakaya, E; McDermott, G; Prestwich, RJ; Ramasamy, S; Roberts, N; Scarsbrook, AF; Sen, M; Speight, R; Subesinghe, M; Sykes, J; Wilson, DJ | 1 |
| Kiess, A; Marashdeh, W; Sheikhbahaei, S; Solnes, L; Subramaniam, RM; Taghipour, M | 1 |
| Ashrafinia, S; Jackson, A; Marcus, C; Rahmim, A; Schmidtlein, CR; Sheikhbahaei, S; Soltani, M; Subramaniam, RM | 1 |
| Barrington, S; Bird, T; Guerrero Urbano, T; Jeannon, JP; Lei, M; Lyons, A; Oakley, R; Simo, R; Thavaraj, S | 1 |
| Califano, J; Fakhry, C; Marcus, C; Subramaniam, RM; Taghipour, M | 1 |
| Chan, SC; Chang, JT; Fan, KH; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yang, LY; Yen, TC | 1 |
| Aggarwal, S; Brizel, DM; Bui, T; Durkee, BY; Hara, WY; Le, QT; Li, R; Loo, BW; Pollom, EL; Song, J; von Eyben, R | 1 |
| Chang, JS; Choi, EC; Keum, KC; Kim, KH; Kim, SH; Lee, CG; Lee, J; Yun, M | 1 |
| Kruse, MJ; Mena, E; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M | 1 |
| Jha, AK; Mena, E; Rahmim, A; Sheikhbahaei, S; Solnes, L; Subramaniam, RM; Taghipour, M | 1 |
| Bourhis, J; Castelli, J; de Bari, B; de Crevoisier, R; Depeursinge, A; Devillers, A; Prior, JO | 1 |
| Chan, SC; Chang, JT; Chin, SC; Huang, SF; Ko, SF; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Alberini, JL; Banal, A; Floiras, JL; Gardner, M; Halimi, P; Hans, S; Housset, M; Labib, A; Plantet, MM; Valinta, D; Wartski, M | 1 |
| Bradford, CR; Bui, C; Chepeha, DB; Eisbruch, A; Frey, KA; Karamchandani, R; Lee, JS; Miller, TH; Mukherji, SK; Oxford, LE; Sacco, AG; Teknos, TN; Urba, SG; Wolf, GT; Worden, FM | 1 |
| Bumpous, JM | 1 |
| Diener, J; Grünwald, F; Kovács, AF; Wallowy, P | 1 |
| Krabbe, CA; Pruim, J; Roodenburg, JL; van der Wal, JE; van der Werff-Regelink, G | 1 |
| Abe, T; Fujita, H; Hayabuchi, N; Ishibashi, M; Kaibara, H; Kaida, H; Kobayashi, M; Kurata, S; Nakashima, T; Tanaka, N; Uchida, M; Uchiyama, Y | 1 |
| Balogh, J; Caldwell, C; Khaouam, N; MacKenzie, R; Mah, K; Poon, I; Tirona, R; Yu, H | 1 |
| Bisdas, S; Chambron-Pinho, N; Mack, M; Middendorp, M; Sader, R; Seitz, O; Vogl, TJ | 1 |
| Bold, B; Ishida, R; Okada, N; Omura, K; Piao, Y; Shibuya, H; Tayier, A | 1 |
| Balink, H; de Visscher, JG; Dijkstra, PU; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF | 1 |
| Agool, A; Brouwers, AH; Dijkstra, PU; Krabbe, CA; Phan, TT; Pruim, J; Roodenburg, JL; Scholtens, AM | 1 |
| Chan, SC; Chang, JT; Liao, CT; Lin, CY; Lo, CW; Ng, SH; Wang, HM; Yen, TC | 1 |
| Fajnwak, P; Farghaly, HR; Nguyen, NC; Osman, MM | 1 |
| Ferris, RL; Hagan, JL; Rabalais, A; Tauzin, M; Walvekar, RR; Wood, CG | 1 |
| Dubois, F; Dumollard, JM; Martin, C; Prades, JM; Prevot, N; Richard, C; Timoshenko, AP | 1 |
| Kositwattanarerk, A | 1 |
| Cacheux, W; Farkhondeh, F; Girodet, J; Paulmier, B; Petras, S; Servois, V | 1 |
| Chan, SC; Chin, SC; Liao, CT; Lin, CY; Ng, SH; Wai, YY; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Balink, H; de Visscher, JG; Dol, J; Krabbe, CA; Roodenburg, JL | 1 |
| Abe, K; Hatakenaka, M; Honda, H; Nakamura, K; Nakashima, T; Nonoshita, T; Ohga, S; Ohnishi, K; Shioyama, Y; Yoshitake, T; Yoshiura, T | 1 |
| Colevas, AD; Fischbein, NJ; Graves, EE; Iagaru, AH; Khong, B; Kong, C; La, TH; Le, QT; Loo, BW; Murphy, JD; Tang, C | 1 |
| Alvarez, AC; Cook, EF; Dibble, EH; Mercier, G; Subramaniam, RM; Truong, MT | 1 |
| Cannon, B; Dong, L; Schwartz, DL | 1 |
| Harada, H; Kurabayashi, T; Mochizuki, Y; Nakamura, S; Omura, K; Shibuya, H | 1 |
| Adams, E; Beveridge, S; Clark, CH; Jordan, T; Nisbet, A; Rickard, D; Teoh, M; Whitaker, S; Wood, K | 1 |
| Chang, JT; Cheng, NM; Hsu, CL; Huang, CG; Liao, CT; Lin, CY; Ng, SH; Tsan, DL; Wang, HM; Yen, TC | 1 |
| Eaton, A; Fury, M; Lee, NY; Lim, R; Ohri, N; Rao, S; Schöder, H; Setton, J; Wong, R | 1 |
| Harari, PM; Jeraj, R; Nyflot, MJ; Perlman, SB; Yip, S | 1 |
| Conessa, C; Foehrenbach, H; Hervé, S; Poncet, JL | 1 |
| Babin, E; Bénateau, H; Béquignon, A; Chesnay, E; Comoz, F; Desmonts, C; Goullet de Rugy, M; Hamon, M | 1 |
| Farag, I; Hain, SF; Jones, J; McGurk, M | 1 |
| Chen, AY; Halkar, R; Hudgins, PA; Schuster, D; Vilaseca, I | 1 |
| De Gersem, W; De Neve, W; Duthoy, W; Thierens, H; Vanderstraeten, B | 1 |
| Döbert, N; Kovács, AF; Landes, CA; Walendzik, H; Zaplatnikov, K | 1 |
| Dijkstra, PU; Gravendeel, JP; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF; van der Wal, JE | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, MR; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Choi, SH; Kim, JS; Kim, MR; Kim, SB; Kim, SY; Lee, SW; Nam, SY; Roh, JL | 1 |
| Balogova, S; Chater, PE; Grahek, D; Hugentobler, A; Kerrou, K; Montravers, F; Périé, S; St Guily, JL; Susini, B; Talbot, JN | 1 |
| Bilodeau, PA; Coleman, TA; Gourin, CG; Patel, VS; Watts, TL; Williams, HT | 1 |
| Arnold, W; Avril, N; Herz, M; Kau, RJ; Kruschke, C; Laubenbacher, C; Saumweber, D; Schwaiger, M; Wagner-Manslau, C; Ziegler, S | 1 |
| Dimitrakopoulou-Strauss, A; Haberkorn, U; Reisser, C; Seifert, E; Strauss, LG | 1 |
| Black, M; Gjedde, A; Yamamoto, YL; Zeitouni, AG | 1 |
| Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Raben, M; Randall, ME; Watson, NE; Williams, DW | 1 |
| Becker, M; Benchaou, M; Donath, A; Lehmann, W; Lemoine, R; Rufenacht, D; Slosman, DO | 1 |
| Allal, A; Bang, P; Becker, M; Dulguerov, P; Guyot, JP; Haenggeli, CA; Lehmann, W; Slosman, D | 1 |
| D'Agostino, RB; Greven, KM; Harkness, BA; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Pfaltz, M; Schmid, S; Steinert, H; Stoeckli, SJ | 1 |
| Haberkorn, U; Schadel, A; Seifert, E; Strauss, LG | 1 |
6 review(s) available for fluorodeoxyglucose f18 and Oropharyngeal Neoplasms
| Article | Year |
|---|---|
PET Imaging of Oral Cavity and Oropharyngeal Cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth; Neoplasm Staging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Prognostic and predictive values of baseline and mid-treatment FDG-PET in oropharyngeal carcinoma treated with primary definitive (chemo)radiation and impact of HPV status: Review of current literature and emerging roles.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Systematic Review and Meta-Analysis of Post-Treatment PET/CT in HPV-Associated Oropharyngeal Cancer.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Evaluation and staging of squamous cell carcinoma of the oral cavity and oropharynx: limitations despite technological breakthroughs.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Sentinel Lymph Node Biopsy | 2013 |
Use of 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography for Patient Management and Outcome in Oropharyngeal Squamous Cell Carcinoma: A Review.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Surgical salvage of cancer of the oropharynx after chemoradiation.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Quality of Life; Salvage Therapy; Treatment Failure | 2009 |
15 trial(s) available for fluorodeoxyglucose f18 and Oropharyngeal Neoplasms
| Article | Year |
|---|---|
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma.
Topics: Alphapapillomavirus; Biomarkers; Carcinoma, Squamous Cell; Circulating Tumor DNA; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Kinetics; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Development and Testing of a Machine Learning Model Using
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Machine Learning; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of
Topics: Chemoradiotherapy; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Early
Topics: Analysis of Variance; Antineoplastic Agents; Cisplatin; Docetaxel; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Tumor Burden | 2020 |
18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO).
Topics: Fluorodeoxyglucose F18; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated | 2021 |
Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Research Design; Squamous Cell Carcinoma of Head and Neck | 2017 |
Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngoscopy; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with (18)F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tyrosine | 2010 |
18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Recurrence; Time Factors | 2009 |
¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.
Topics: Biological Transport; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for ¹⁸F-FDG-PET-guided dose escalation in oropharyngeal cancer: a planning study.
Topics: Aged; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Treatment Outcome | 2013 |
Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Korea; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Treatment Outcome | 2007 |
122 other study(ies) available for fluorodeoxyglucose f18 and Oropharyngeal Neoplasms
| Article | Year |
|---|---|
Incidental uptake of fluorodeoxyglucose in the Waldeyer's ring and risk of oropharyngeal malignancy.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
SUV
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
PET/CT versus triple endoscopy in initial workup of HPV+ oropharyngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Endoscopy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Prospective Study of PET/MRI Tumor Response During Chemoradiotherapy for Patients With Low-risk and Intermediate-risk p16-positive Oropharynx Cancer.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2022 |
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
Topics: Alphapapillomavirus; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neck Dissection; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
Topics: Adult; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Staging; Oropharyngeal Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Robotic Surgical Procedures; Squamous Cell Carcinoma of Head and Neck | 2022 |
Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT.
Topics: Extranodal Extension; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
External validation of an
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Incidence and predictive factors of retropharyngeal lymph node metastases in patients with oropharyngeal cancer undergoing multimodality treatment planning imaging.
Topics: Fluorodeoxyglucose F18; Humans; Incidence; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies | 2023 |
Post-treatment 18F-fludeoxyglocuse-positron emission tomography in human papillomavirus-associated oropharyngeal cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human Papillomavirus Viruses; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Retrospective Studies | 2023 |
A comparison of loco-regional relapse pattern in HPV positive vs negative oropharyngeal cancers following radiotherapy; relation to pretreatment FDG-PET and radiotherapy target volumes.
Topics: Chronic Disease; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Squamous Cell Carcinoma of Head and Neck | 2023 |
High nodal FDG uptake increases risk of distant metastasis in patients with oropharyngeal squamous cell carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes.
Topics: Aged; Cohort Studies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2020 |
Prediction of the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma by FDG-PET imaging dataset using deep learning analysis: A hypothesis-generating study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Datasets as Topic; Deep Learning; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Oropharyngeal Neoplasms; Oropharynx; Papillomavirus Infections; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
PET/MRI and genetic intrapatient heterogeneity in head and neck cancers.
Topics: Aged; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genes, Neoplasm; Genes, p53; Genetic Heterogeneity; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Mutation; Neoplasms, Multiple Primary; Oropharyngeal Neoplasms; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptor, Notch1 | 2020 |
Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
Topics: Aged; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck | 2020 |
Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Analyzing oropharyngeal cancer survival outcomes: a decision tree approach.
Topics: Adult; Aged; Aged, 80 and over; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2020 |
CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Topics: Biomarkers; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2021 |
PET-CT scan-based maximum standardized uptake value as a prognostic predictor in oropharynx squamous cell cancer.
Topics: Adult; Aged; Chemoradiotherapy; Disease-Free Survival; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution | 2021 |
Analysis of PET parameters as prognosticators of survival and tumor extent in Oropharyngeal Cancer treated with surgery and postoperative radiotherapy.
Topics: Adult; Aged; Disease Progression; Disease-Free Survival; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Oropharynx; Pharyngectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Tumor Burden | 2021 |
Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging.
Topics: Cohort Studies; Deep Learning; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2021 |
Intrinsic radiomic expression patterns after 20 Gy demonstrate early metabolic response of oropharyngeal cancers.
Topics: Fluorodeoxyglucose F18; Humans; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Retrospective Studies | 2021 |
FDG-PET/CT identified distant metastases and synchronous cancer in squamous cell carcinoma of the head and neck: the impact of smoking and P16-s.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Retrospective Studies; Smoking; Squamous Cell Carcinoma of Head and Neck | 2022 |
Texture Indices of 18F-FDG PET/CT for Differentiating Squamous Cell Carcinoma and Non-Hodgkin's Lymphoma of the Oropharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies | 2021 |
Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Clinical Decision-Making; Combined Modality Therapy; Deep Learning; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; ROC Curve; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Workflow | 2021 |
Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using
Topics: Adult; Aged; Chemoradiotherapy; Cost-Benefit Analysis; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2017 |
FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Neoplasm Metastasis; Oropharyngeal Neoplasms; Positron-Emission Tomography; ROC Curve; Treatment Outcome; Tumor Burden | 2017 |
Contrast-enhanced ultrasound for diagnosis of an enlarged cervical lymph node in a patient with oropharyngeal cancer: a case report.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Oropharyngeal Neoplasms; Phospholipids; Positron-Emission Tomography; Radiopharmaceuticals; Sulfur Hexafluoride; Tomography, X-Ray Computed; Ultrasonography | 2017 |
Heterogeneity and irregularity of pretreatment
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Genes, p16; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis | 2018 |
Correlation of human papilloma virus status with quantitative perfusion/diffusion/metabolic imaging parameters in the oral cavity and oropharyngeal squamous cell carcinoma: comparison of primary tumour sites and metastatic lymph nodes.
Topics: Aged; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Organometallic Compounds; Oropharyngeal Neoplasms; Papillomaviridae; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
Significance of Negative Posttreatment 18-FDG PET/CT Imaging in Patients With p16/HPV-Positive Oropharyngeal Cancer.
Topics: Adult; Aged; Cyclin-Dependent Kinase Inhibitor p16; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomaviridae; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tumor Burden | 2018 |
Oropharyngeal Squamous Cell Carcinoma Metastasis to Distal Skeletal Muscle on FDG PET/CT.
Topics: Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography | 2018 |
Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2018 |
Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Hypopharyngeal Neoplasms; Male; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Sensitivity and Specificity; Tumor Burden | 2019 |
Volumetric
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Smoking; Survival Rate; Treatment Failure; Tumor Burden | 2019 |
Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2019 |
FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm, Residual; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2019 |
Incidentally Detected Oropharyngeal Squamous Cell Carcinoma on 18F-Fluciclovine PET/CT.
Topics: Aged; Carboxylic Acids; Carcinoma, Squamous Cell; Cyclobutanes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2019 |
Clinical Value of Fused PET/MRI for Surgical Planning in Patients With Oral/Oropharyngeal Carcinoma.
Topics: Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Invasiveness; Oropharyngeal Neoplasms; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2020 |
Cystic form of cervical lymphadenopathy. Guidelines of the French Society of Otorhinolaryngology - Head and Neck Surgery (SFORL). Part 1: Diagnostic procedures for lymphadenopathy in case of cervical mass with cystic aspect.
Topics: Adult; Biopsy, Fine-Needle; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image-Guided Biopsy; Lymphadenopathy; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2019 |
Impact of positron emission tomography with the use of fluorodeoxyglucose on response to induction chemotherapy in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Male; Middle Aged; Oropharyngeal Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2013 |
Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Alphapapillomavirus; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2014 |
The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Incidence; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Smoking; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Prospective Studies; ROC Curve; Tomography, X-Ray Computed | 2013 |
Relationship between extracapsular spread and FDG PET/CT in oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Survival Analysis; Tomography, X-Ray Computed | 2013 |
FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron-Emission Tomography; Smoking; Tomography, X-Ray Computed | 2014 |
Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Response from authors of "reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer".
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Reliability of post-chemo radiotherapy F-18-FDG PET/CT for prediction of loco regional failure in human papillomavirus-associated oropharyngeal cancer: misconception and misinterpretation.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cone-Beam Computed Tomography; Cyclin-Dependent Kinase Inhibitor p16; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tomography, X-Ray Computed; Tumor Suppressor Protein p53 | 2015 |
The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron em
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis | 2014 |
Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm, Residual; Oropharyngeal Neoplasms; Patient Care Planning; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2014 |
Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomaviridae; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tumor Burden | 2014 |
Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2016 |
Prognostic value of SUVmean in oropharyngeal and hypopharyngeal cancers: comparison with SUVmax and other volumetric parameters of 18F-FDG PET.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Oropharyngeal Neoplasms; Papillomaviridae; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
18F-fluorodeoxyglucose uptake level-based lymph node staging in oropharyngeal squamous cell cancer--role of molecular marker expression on diagnostic outcome.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Molecular Diagnostic Techniques; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.
Topics: Adult; Aged; Blood Glucose; Chemoradiotherapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
Topics: Carcinoma, Squamous Cell; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Organs at Risk; Oropharyngeal Neoplasms; Pattern Recognition, Automated; Positron-Emission Tomography; Proton Therapy; Protons; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tomography, X-Ray Computed | 2015 |
Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Topics: Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neck; Oropharyngeal Neoplasms; Palpation; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; ErbB Receptors; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Squamous Cell Carcinoma of Head and Neck | 2016 |
Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
(18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Risk Assessment; Treatment Outcome | 2016 |
The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Comorbidity; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Maryland; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate | 2015 |
Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2016 |
Prognostic value of midtreatment FDG-PET in oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Disease-Free Survival; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tumor Burden | 2016 |
Prognostic value of FDG-PET volumetric parameters in patients with p16-positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiotherapy; Retrospective Studies; Tumor Burden | 2016 |
Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2017 |
Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis | 2017 |
Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control?
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Proportional Hazards Models; Retrospective Studies; Tumor Burden | 2017 |
Use of single MRI and 18F-FDG PET-CT scans in both diagnosis and radiotherapy treatment planning in patients with head and neck cancer: advantage on target volume and critical organ delineation.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Parotid Gland; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2009 |
18F-FDG PET for detecting metastases and synchronous primary malignancies in patients with oral and oropharyngeal cancer.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Oropharyngeal Neoplasms; Palatal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tongue Neoplasms | 2009 |
The utility of FDG-PET for detecting multiple primary cancers in hypopharyngeal cancer patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2009 |
Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2009 |
18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.
Topics: Carboplatin; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Nuclear Medicine; Observer Variation; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
18f-fdg pet for routine posttreatment surveillance in oral and oropharyngeal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Monitoring, Physiologic; Mouth Neoplasms; Oropharyngeal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results | 2010 |
PET-CT staging of the neck in cancers of the oropharynx: patterns of regional and retropharyngeal nodal metastasis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2010 |
Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Oropharyngeal Neoplasms; Polymerase Chain Reaction; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
PET/CT in oral cavity and oropharyngeal cancer in post therapy setting.
Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Amoebic abscess diagnosed on fluorodeoxyglucose positron emission tomography scan in patient with recurrent oropharyngeal squamous cell carcinoma.
Topics: Aged; Amebiasis; Carcinoma, Squamous Cell; Colonic Diseases; Fluorodeoxyglucose F18; Humans; Male; Oropharyngeal Neoplasms; Positron-Emission Tomography | 2011 |
Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Prediction of local failures with a combination of pretreatment tumor volume and apparent diffusion coefficient in patients treated with definitive radiotherapy for hypopharyngeal or oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hemoglobins; Humans; Male; Middle Aged; Multivariate Analysis; Oropharyngeal Neoplasms; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy; Recurrence; Retrospective Studies; Treatment Outcome | 2011 |
Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; Female; Fluorodeoxyglucose F18; Humans; Karnofsky Performance Status; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Mouth Neoplasms; Multivariate Analysis; Neoplasm Staging; Neoplasms, Squamous Cell; Oropharyngeal Neoplasms; Prognosis; Proportional Hazards Models; Retrospective Studies; Tumor Burden | 2012 |
Metabolic imaging biomarkers of postradiotherapy xerostomia.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Organs at Risk; Oropharyngeal Neoplasms; Parotid Gland; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Xerostomia | 2012 |
Preoperative predictive model of cervical lymph node metastasis combining fluorine-18 fluorodeoxyglucose positron-emission tomography/computerized tomography findings and clinical factors in patients with oral or oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anatomy, Regional; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2012 |
Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Human Papillomavirus DNA Tests; Humans; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.
Topics: Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Metastasis; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx.
Topics: Adult; Aged; Brain Neoplasms; Cell Hypoxia; Cell Proliferation; Coordination Complexes; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Oropharyngeal Neoplasms; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thiosemicarbazones; Tomography, X-Ray Computed | 2012 |
FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Oropharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[Interest of PET/CT scan fusion to assess mandible involvement in oral cavity and oro pharyngeal carcinomas].
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Mandibular Neoplasms; Middle Aged; Mouth; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Positron emission tomography (PET) in the management of oro-pharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?
Topics: Adult; Aged; Carcinoma, Squamous Cell; Contrast Media; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neck; Neoplasm, Residual; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Implementation of biologically conformal radiation therapy (BCRT) in an algorithmic segmentation-based inverse planning approach.
Topics: Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Models, Biological; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal | 2006 |
The diagnostic role of radioactivity in sentinel nodes in oral and oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2006 |
FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Decision Making; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2008 |
Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Endoscopy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Oropharyngeal Neoplasms; Tomography, Emission-Computed | 1995 |
Functional imaging of head and neck tumors using positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cerebellum; Cicatrix; Deoxyglucose; Female; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Pituitary Neoplasms; Tomography, Emission-Computed; Tonsillar Neoplasms | 1994 |
Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
Topics: Carcinoma; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Paranasal Sinus Neoplasms; Prognosis; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cervical Vertebrae; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Oropharynx; Retrospective Studies; Spinal Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
[Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma].
Topics: Biopsy; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Oropharyngeal Neoplasms; Predictive Value of Tests; Tomography, Emission-Computed | 2000 |
Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Oropharyngeal Neoplasms; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
[Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Carcinoma; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Tomography, Emission-Computed | 1992 |